A Study for Patients With Non-Hodgkin's Lymphomas

Clinical trial NCT00542919 · COMPLETED

Trial details

NCT number: NCT00542919
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

T-Cell Lymphoma B-Cell Lymphoma

Start date: 2007-11-01
Primary completion: 2010-03-01
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.